Mental Health Channel
Topics & Medications
Related Channels

Generic Vivactil

Vivactil® (protriptyline hydrochloride) is a prescription medication that has been licensed as a depression treatment. The medication is part of a class of drugs known as tricyclic antidepressants.
Brand-name Vivactil is currently manufactured by Duramed Pharmaceuticals. Although Merck was the first manufacturer of Vivactil many years ago, Duramed now holds the rights to make brand-name Vivactil. Also, it has since come off patent and is available as a generic.

Strengths of Generic Vivactil

Generic Vivactil tablets are available in the following strengths:
  • Protriptyline 5 mg
  • Protriptyline 10 mg.

Who Makes Generic Vivactil?

Generic Vivactil is made by the following manufacturers:
  • Roxane Laboratories
  • SigmaPharm Laboratories, LLC.

Is Generic Protriptyline as Good as Vivactil?

All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. Generic protriptyline has an "AB" rating, meaning it should be equivalent to Vivactil.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers or dyes or other ingredients that may cause problems for people with allergies or sensitivities.
4 Relationship Skills for People With ADHD

Vivactil Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.